| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue |
-
|
-
|
-
| | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit |
-
|
-
|
-
| | | Operating Expenses | | Research Development | 10,926 | 11,535 | 9,041 | | Selling General and Administrative | 3,581 | 4,624 | 3,461 | | Non Recurring |
-
|
-
|
-
| | Others | 40 | 654 | 485 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,546) | (16,812) | (12,987) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 481 | 1,235 | 1,028 | | Earnings Before Interest And Taxes | (14,066) | (15,577) | (11,959) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (14,066) | (15,577) | (11,959) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,066) | (15,577) | (11,959) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,066) | (15,577) | (11,959) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,066) | ($15,577) | ($11,959) |
|
1.48% Nasdaq 
Income Statement
